Dopa < Dopamine < Dosage

Facettes :

List of bibliographic references indexed by Dopamine

Number of relevant bibliographic references: 183.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000B82 (2014)	Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]	The effects of dopaminergic medication on dynamic decision making in Parkinson's disease
000B83 (2014)	Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada]	The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000C04 (2014)	Claudine Habak [Canada] ; Anne Noreau [Canada] ; Atsuko Nagano-Saito [Canada] ; Beatriz Mejia-Constain [Canada] ; Clotilde Degroot [Canada] ; Antonio P. Strafella [Canada] ; Sylvain Chouinard [Canada] ; Anne-Louise Lafontaine [Canada] ; Guy A. Rouleau [Canada] ; Oury Monchi [Canada]	Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease
000C08 (2014)	D. Ouazia [Canada] ; L.-C. Jr Levros [Canada] ; E. Rassart [Canada] ; R. R. Desrosiers [Canada]	DOPAMINE DOWN-REGULATION OF PROTEIN L-ISOASPARTYL METHYLTRANSFERASE IS DEPENDENT ON REACTIVE OXYGEN SPECIES IN SH-SY5Y CELLS
000C09 (2014)	Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]	Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment
000C13 (2014)	Mauro Pettorruso [Italie] ; Giovanni Martinotti [Italie] ; Alfonso Fasano [Canada] ; Giovanna Loria [Italie] ; Marco Di Nicola [Italie] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie]	Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study
001052 (2013)	JI HYUN KO [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada]	Prefrontal Dopaminergic Receptor Abnormalities and Executive Functions in Parkinson's Disease
001062 (2013)	Philip Seeman [Canada] ; Michele Tinazzi [Italie]	Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia
001065 (2013)	David Mongeon [Canada] ; Pierre Blanchet [Canada] ; Julie Messier [Canada]	Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations
001074 (2013)	Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]	Dopaminergic contributions to distance estimation in Parkinson's disease: A sensory-perceptual deficit?
001081 (2013)	Edward Stein [Israël] ; Izhar Bar-Gad [Israël]	Beta oscillations in the cortico-basal ganglia loop during parkinsonism
001390 (2012)	S. Al Sweidi [Canada] ; M. G. Sánchez [Canada] ; M. Bourque [Canada] ; M. Morissette [Canada] ; D. Dluzen [États-Unis] ; T. Di Paolo [Canada]	Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease
001443 (2012)	Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis]	Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease
001483 (2012)	Dominic Nadeau [Canada] ; Isabelle Giroux [Canada] ; Julie Dufour [Canada] ; Martine Simard [Canada]	Jeu pathologique chez les patients atteints de la maladie de Parkinson
001493 (2012)	D. Domenger [Canada] ; D. Dea [Canada] ; L. Theroux [Canada] ; L. Moquin [Canada] ; A. Gratton [Canada] ; J. Poirier [Canada]	The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain
001495 (2012)	Sébastien Helie [États-Unis] ; Erick J. Paul [États-Unis] ; F. Gregory Ashby [États-Unis]	Simulating the effects of dopamine imbalance on cognition: From positive affect to Parkinson's disease
001509 (2012)	John S. Yeomans [Canada]	Muscarinic Receptors in Brain Stem and Mesopontine Cholinergic Arousal Functions
001515 (2012)	Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada]	Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
001537 (2012)	Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada]	Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study
001538 (2012)	Aimee J. Nelson [Canada] ; Azra Premji [Canada] ; Navjot Rai [Canada] ; Tasnuva Hoque [Canada] ; Mark Tommerdahl [États-Unis] ; Robert Chen [Canada]	Dopamine Alters Tactile Perception in Parkinson's Disease
001825 (2011)	A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]	Milestones in neuroimaging

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Dopamine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022